Navigation Links
Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy

Monday saw the conclusion of the first of a wave of prescription drug trials with the hearing of the closing arguments as Wyeth defended// its hormone replacement therapy Prempro against claims of increased risk of heart disease, stroke and cancer.

Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the jury at the federal court in Little Rock said, "Wyeth was negligent in not testing the drug and not knowing the truth about their drug."

However Wyeth's lawyer Jane Bockus told the panel of nine women and three men that the company had been warning doctors as early as 1991 of a reported increase in malignancies among patients taking its hormone replacement therapy and that the therapy should not be prescribed for over a year without a follow-up exam.

On Reeves testimony it was revealed that she took Prempro for more than eight years.

Bockus said, "Clearly the label contained adequate information," to allow doctors to decide on patient treatment.

This is the first trial of 5,000 lawsuits filed against Wyeth for Prempro.

Reeves, 67, and her lawyer told the jury at the U.S. Court for the Eastern District of Arkansas that consuming Prempro caused the growth of a breast tumor, for which she had to undergo a mastectomy.

Prempro is a combination of the hormones estrogen and progesterone to overcome the effects of menopause and has been sold in the United States since 1995.

Wyeth’s lawyers argued that the drug company had met its ethical and legal obligations in determining the treatment's safety, before U.S. District Judge William R. Wilson, Jr.

Reeves’ lawyers have said that she is seeking an unspecified judgment that could exceed $1 million.


NL
'"/>




Page: 1

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Pharma Wins Law Suit
3. Verdict Against Wyeth Pharma in Prempro Case
4. Simmering Curry - Murg Masala Embroiled In a Thick Soup
5. Medical Education in Australia Embroiled in Scandals
6. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
7. Lawsuit Against Sunscreen Makers For False Claims of Protection Against Skin Cancer
8. Lawsuit against Google
9. KFC Targeted in Lawsuit
10. American Wins Lawsuit Over Penile Implant Malfunction
11. Soft Drink Companies Settle Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: